HighlightsA brief glimpse into the past
NLB ABA League 2 2023/24, QF Round 2 match: Vojvodina mts – Sutjeska Elektroprivreda (17.4.2024)
Take a look at the full match video of NLB ABA League 2 2023/24 season game between Vojvodina mts and Sutjeska ...
NLB ABA League 2 2023/24 highlights, QF Round 2: Vojvodina mts – Sutjeska Elektroprivreda, (17.4.24)
Take a look at the highlights of the 2023/24 season NLB ABA League 2 game between Vojvodina mts and Sutjeska ...
Block by Vladimir Tomašević (Vojvodina mts – Sutjeska Elektroprivreda, 17.4.2024)
Vladimir Tomašević came up with this block in the game of his Sutjeska Elektroprivreda against Vojvodina mts in Spens Sports ...
NLB ABA League 2 2023/24, Round 12 match: Vojvodina mts – TFT Mozzart Skopje (21.3.2024)
Take a look at the full match video of NLB ABA League 2 2023/24 season game between Vojvodina mts and TFT Mozzart Skopje ...
NLB ABA League 2 2023/24, Round 10 match: MZT Skopje Aerodrom - Vojvodina mts (4.2.2024)
Take a look at the full match video of NLB ABA League 2 2023/24 season game between MZT Skopje Aerodrom and Vojvodina ...
NLB ABA League 2 2023/24 highlights, Round 10: MZT Skopje Aerodrom - Vojvodina mts, (4.2.2024)
Take a look at the highlights of the 2023/24 season NLB ABA League 2 game between MZT Skopje Aerodrom and Vojvodina mts ...
Team, Place & City Details
SD Vojvodina
Sportsko društvo Vojvodina , commonly abbreviated as SD Vojvodina Novi Sad, formed in 1914, is a multi-sport club in Novi Sad, Serbia.
Brolucizumab
Brolucizumab, sold under the trade name Beovu, is a humanized single-chain antibody fragment for the treatment of neovascular age-related macular degeneration (AMD).The most common side effects are reduced visual acuity, cataract (clouding of the lens in the eye), conjunctival haemorrhage (bleeding at the front of the eye) and vitreous floaters (spots in the vision). The most serious side effects are blindness, endophthalmitis (an infection inside the eye), retinal artery occlusion (blockage of the artery in the retina) and retinal detachment (separation of the retina from the back of the eye).Brolucizumab was designed to attach to and block a substance called vascular endothelial growth factor A (VEGF-A).